Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Owen

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Gut|April 15, 2008
How does interferon inhibit HCV cell entry?Meleri Jones, James S Owen
Atherosclerosis. Supplements|February 8, 2003
ATP-binding cassette A1 protein and HDL homeostasisJames S Owen, Jane V Mulcahy
The Journal of Gene Medicine|January 21, 2009
Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editingIoannis Papaioannou, Petra Disterer, James S Owen
Current Opinion in Molecular Therapeutics|September 8, 2006
ApoE gene therapy to treat hyperlipidemia and atherosclerosisJulian D Harris, Vanessa Evans, James S Owen
Cardiology Research and Practice|May 31, 2012
Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 ProteinIoannis Papaioannou, J Paul Simons, James S Owen
Expert Opinion on Biological Therapy|February 11, 2012
Oligonucleotide-directed gene-editing technology: mechanisms and future prospectsIoannis Papaioannou, J Paul Simons, James S Owen
International Journal of Experimental Pathology|May 13, 2023
Clinical applications of gene therapy for rare diseases: A reviewIoannis Papaioannou, James S Owen, Rafael J Yáñez-Muñoz
FEBS Letters|April 12, 2003
Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cellsSandra M Sacre, Anita K Stannard, James S Owen
Molecular Reproduction and Development|March 26, 2005
Lack of RNA-DNA oligonucleotide (chimeraplast) mutagenic activity in mouse embryosAristides D Tagalakis, James S Owen, J Paul Simons
The Biochemical Journal|October 23, 2003
Human scavenger receptor class B type II (SR-BII) and cellular cholesterol effluxJane V Mulcahy, Dave R Riddell, James S Owen
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Gut|April 15, 2008
How does interferon inhibit HCV cell entry?Meleri Jones, James S Owen
Atherosclerosis. Supplements|February 8, 2003
ATP-binding cassette A1 protein and HDL homeostasisJames S Owen, Jane V Mulcahy
The Journal of Gene Medicine|January 21, 2009
Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editingIoannis Papaioannou, Petra Disterer, James S Owen
Current Opinion in Molecular Therapeutics|September 8, 2006
ApoE gene therapy to treat hyperlipidemia and atherosclerosisJulian D Harris, Vanessa Evans, James S Owen
Cardiology Research and Practice|May 31, 2012
Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 ProteinIoannis Papaioannou, J Paul Simons, James S Owen
Expert Opinion on Biological Therapy|February 11, 2012
Oligonucleotide-directed gene-editing technology: mechanisms and future prospectsIoannis Papaioannou, J Paul Simons, James S Owen
International Journal of Experimental Pathology|May 13, 2023
Clinical applications of gene therapy for rare diseases: A reviewIoannis Papaioannou, James S Owen, Rafael J Yáñez-Muñoz
FEBS Letters|April 12, 2003
Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cellsSandra M Sacre, Anita K Stannard, James S Owen
Molecular Reproduction and Development|March 26, 2005
Lack of RNA-DNA oligonucleotide (chimeraplast) mutagenic activity in mouse embryosAristides D Tagalakis, James S Owen, J Paul Simons
The Biochemical Journal|October 23, 2003
Human scavenger receptor class B type II (SR-BII) and cellular cholesterol effluxJane V Mulcahy, Dave R Riddell, James S Owen
Pageof 4